Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Cyclacel Pharmaceuticals (CYCC) Q4 2024 Earnings
CYCC
12
Nov
Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-6.23
-4.21
-2.2
-0.18
Details
Expected EPS
-0.54
Actual EPS
-0.18
Surprise EPS
0.36
Surprise Percent
+66.67%
Description
Cyclacel Pharmaceuticals (CYCC) has reported earnings of -0.18 per share for Q4 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login